跳至主要内容
临床试验/JPRN-UMIN000005800
JPRN-UMIN000005800招募中未知

A feasibility study of chemotherapy with vinorelbine plus bevacizumab in elderly patients with non-small lung cancer - A feasibility study of chemotherapy with vinorelbine plus bevacizumab in elderly patients with non-small lung cancer

Toho University Omori Medical Center0 个研究点目标入组 15 人开始时间: 2011年6月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Receiving a blood transfusion, hematopoietic factor, anticoagulant drug 2 weeks prior to enrollment. 2) Severe renal function disorder 2+ or higher proteinuria within 2 weeks prior to enrollment. 3) Serious drug allergy. 4) Active synchronous malignancies. 5) Uncontrolled Active infection. 6) Uncontrollable hypertension, uncontrollable diabetes. 7) Clinically significant heart disease. 8)Thromboembolism, interstitial pneumonia, pulmonary fibrosis and severe emphysema within the past one year. 9)Traumatic fracture of unrecovery 10) Mental disorder, central nervous system disorders, cerebrovascular disorders. 11) Permeation of the neoplastic cell in large vessels. 12) Hollowing out of the tumor. 13) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.

研究者

相似试验